Author:
Huang Dan-Ping,Chen Yi-Jun,Luo Jie-Si,Chen Shao-Qian,Cheng Jing,Li Yu,Liang Cong,Wang Li-Na,Fan Zhong,Zhang Xiao-Li,Luo Xue-Qun,Huang Li-Bin,Tang Yan-Lai
Abstract
Acute promyelocytic leukemia (APL) is a special type of acute myeloid leukemia (AML), accounting for about 5% to 10% of children with AML. At the genetic level, APL is featured by a unique chromosome translocation t(15;17) which results in the PML-RARA gene fusion. Most patients can be diagnosed by traditional karyotype analysis, Fluorescence-In-Situ Hybridization (FISH), or Reverse Transcription-Polymerase Chain Reaction (RT-PCR). We report the case of a child with acute promyelocytic leukemia (APL) who had characteristic chromosome translocation t(15;17) and rare PML-RARA gene mutation. This patient had an excellent response to chemotherapy, suggesting that this mutation will not affect the treatment and prognosis of APL.